SCHEMBL3615799

SCHEMBL3615799

[Li]c1cc(C)ccc1F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5702297 0.79
SCHEMBL130515 0.75
SCHEMBL29441288 0.75
SCHEMBL652313 0.74
SCHEMBL3163208 0.72
Ammonia Solution, Strong SCHEMBL20593640 0.72 NFE2L2 (0.60)
Bromide SCHEMBL28031489 0.72 NFE2L2 (0.60)
SCHEMBL13830012 0.72 NISCH (0.52)
SCHEMBL91411 0.72
SCHEMBL29901001 0.72 NISCH (0.52)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8487108-B2 Piperidinyl carbamate intermediates for the synthesis of aspartic protease inhibitors VITAE PHARMACEUTICALS, INC. (US) 2013-07-16 US disclosed
EP-1966139-B1 ASPARTIC PROTEASE INHIBITORS VITAE PHARMACEUTICALS INC (US) 2011-12-21 EP disclosed
US-20100048636-A1 Aspartic Protease Inhibitors VITAE PHARMACEUTICALS, INC. 2010-02-25 US disclosed